相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers
Y. Wattanagoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus: Review of Clinical Issues
Timothy M. Uyeki
CLINICAL INFECTIOUS DISEASES (2009)
Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
Scott A. Harper et al.
CLINICAL INFECTIOUS DISEASES (2009)
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection
Jerry R. Aldridge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A nationally coordinated laboratory system for human avian influenza a (H5N1) in Thailand: program design, analysis, and evaluation
Rungrueng Kitphati et al.
CLINICAL INFECTIOUS DISEASES (2008)
De testimonio: on the evidence for decisions about the use of therapeutic interventions
Michael Rawlins
LANCET (2008)
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series
I. Nyoman Kandun et al.
LANCET (2008)
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China
Hua Wang et al.
LANCET (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China
Hongjie Yu et al.
PLOS ONE (2008)
Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza
Walter R. J. Taylor et al.
PLOS ONE (2008)
Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam
Mai T. Q. Le et al.
PLOS ONE (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
Arun K. Kashyap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
GRADE:: going from evidence to recommendations
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Treatment with convalescent plasma for influenza A (H5N1) infection
Boping Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
H5N1 infection of the respiratory tract and beyond: a molecular pathology study
Jiang Gu et al.
LANCET (2007)
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006
Endang R. Sedyaningsih et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
Cameron P. Simmons et al.
PLOS MEDICINE (2007)
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
Elena A. Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
WHO rapid advice guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
Holger J. Schunemann et al.
LANCET INFECTIOUS DISEASES (2007)
Adverse events associated with high-dose ribavirin: Evidence from the Toronto outbreak of severe acute respiratory syndrome
Matthew P. Muller et al.
PHARMACOTHERAPY (2007)
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
Brendon J. Hanson et al.
RESPIRATORY RESEARCH (2006)
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Menno D. de Jong et al.
NATURE MEDICINE (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
HL Yen et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids
JF Griffith et al.
RADIOLOGY (2005)
Immune reconstitution in HIV-infected patients
HH Hirsch et al.
CLINICAL INFECTIOUS DISEASES (2004)
Medical progress: HIV drug resistance
F Clavel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Re-emergence of fatal human influenza A subtype H5N1 disease
JSM Peiris et al.
LANCET (2004)
Avascular necrosis of bone in severe acute respiratory syndrome
N Hong et al.
CLINICAL RADIOLOGY (2004)
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials
NJ Cooper et al.
BRITISH MEDICAL JOURNAL (2003)
Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997
PKS Chan
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
